Childhood Fibrolamellar Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Childhood Fibrolamellar Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 1/2

NCT06620302

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Soli…

This phase I/II trial tests the safety, side effects and best dose of DT2216 in combination with irinotecan and how well it works in treating children, adolesce…

United States81 participantsStarted 2025-06-12

Treatment: Bcl-XL Proteolysis Targeting Chimera DT2216, Biospecimen Collection

RecruitingPhase 2

NCT04134559

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

This research study is studying an immunotherapy drug (pembrolizumab or KEYTRUDA) as a possible treatment for pediatric hepatocellular carcinoma or hepatocellul…

United States18 participantsStarted 2020-11-01

Treatment: Pembrolizumab

All recent trials (3 shown)

Active — Not RecruitingPhase 3

NCT03533582

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After S…

This partially randomized phase II/III trial studies how well, in combination with surgery, cisplatin and combination chemotherapy works in treating children an…

United States537 participantsStarted 2018-05-24

Treatment: Biospecimen Collection, Carboplatin